Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7406)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang HJ, Yao DF, Yao M, Huang H, Wang L, Yan MJ, Yan XD, Gu X, Wu W, Lu SL. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells. World J Gastroenterol 2013; 19(24): 3792-3801 [PMID: 23840117 DOI: 10.3748/wjg.v19.i24.3792] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i24/3792.htm |
| Number | Citing Articles |
| 1 |
Jiangbo Zhang, Jin Cheng, Zhenzhen Zeng, Yongfeng Wang, Xiaojun Li, Qing Xie, Junqiao Jia, Ying Yan, Zhengyang Guo, Jian Gao, Mingjie Yao, Xiangmei Chen, Fengmin Lu. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma. Oncotarget 2015; 6(39): 42040 doi: 10.18632/oncotarget.5969
|
| 2 |
Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022; 14(19): 4647 doi: 10.3390/cancers14194647
|
| 3 |
Min Yao, Li Wang, Zhizhen Dong, Qi Qian, Yun Shi, Dandan Yu, Shiye Wang, Wenjie Zheng, Dengfu Yao. Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy. Tumor Biology 2014; 35(6): 5857 doi: 10.1007/s13277-014-1776-5
|
| 4 |
Llara Prieto-Fernández, Sofía T. Menéndez, María Otero-Rosales, Irene Montoro-Jiménez, Francisco Hermida-Prado, Juana M. García-Pedrero, Saúl Álvarez-Teijeiro. Pathobiological functions and clinical implications of annexin dysregulation in human cancers. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1009908
|
| 5 |
Huhu Zhang, Zhe Zhang, Tingting Guo, Guang Chen, Guoxiang Liu, Qinghang Song, Guichun Li, Fenghua Xu, Xiaolei Dong, Fanghao Yang, Can Cao, Di Zhong, Shuang Li, Ya Li, Mengjun Wang, Bing Li, Lina Yang. Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1141331
|
| 6 |
Xing Liu, Yongyi Bi. Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration. Medical Science Monitor 2016; 22: 3529 doi: 10.12659/MSM.897594
|
| 7 |
Ning-Chia Chang, Yu-Jen Wu, Ling-Feng Wang, Leong-Perng Chan, Chee-Yin Chai, Wan-Tzu Chen, MS, Shih-Meng Tsai, Chen-Yu Chien, Kuen-Yao Ho. Downregulation of Calreticulin and Annexin A2 Expression in Acquired Middle Ear Cholesteatoma by 2-DE Analysis. Annals of Otology, Rhinology & Laryngology 2023; 132(6): 684 doi: 10.1177/00034894221111255
|
| 8 |
Junrong Li, Liqun Wang, Xinyue Zhang, Xiaozhi Wen, Xinyan Wei, Qiwei Qin, Shaowen Wang. Grouper annexin A2 affects RGNNV by regulating the host immune response. Fish & Shellfish Immunology 2023; 137: 108771 doi: 10.1016/j.fsi.2023.108771
|
| 9 |
Kai-Ming Gao, Xin-cheng Chen, Jun-xia Zhang, Yingyi Wang, Wei Yan, Yong-Ping You. A pseudogene-signature in glioma predicts survival. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0137-6
|
| 10 |
Haruna Fujimori, Mao Shima‐Nakamura, Shin‐Ichiro Kanno, Rie Shibuya‐Takahashi, Mai Mochizuki, Masamichi Mizuma, Michiaki Unno, Yuta Wakui, Makoto Abue, Wataru Iwai, Daisuke Fukushi, Kennich Satoh, Kazunori Yamaguchi, Norihisa Shindo, Jun Yasuda, Keiichi Tamai. FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma. Cancer Science 2024; doi: 10.1111/cas.16140
|
| 11 |
Guilherme Ribeiro Romualdo, Tony Fernando Grassi, Renata Leme Goto, Mariana Baptista Tablas, Lucas Tadeu Bidinotto, Ana Angélica Henrique Fernandes, Bruno Cogliati, Luís Fernando Barbisan. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features. Toxicology Letters 2017; 281: 84 doi: 10.1016/j.toxlet.2017.09.015
|
| 12 |
Yong Wang, Wei Xu, Maoheng Zu, Hao Xu. Circular RNA circ_0021093 regulates miR-432/Annexin A2 pathway to promote hepatocellular carcinoma progression. Anti-Cancer Drugs 2021; 32(5): 484 doi: 10.1097/CAD.0000000000001053
|
| 13 |
L C Stetson, Quinn T Ostrom, Daniela Schlatzer, Peter Liao, Karen Devine, Kristin Waite, Marta E Couce, Peggy L R Harris, Amber Kerstetter-Fogle, Michael E Berens, Andrew E Sloan, Mohammad M Islam, Vilashini Rajaratnam, Shama P Mirza, Mark R Chance, Jill S Barnholtz-Sloan. Proteins inform survival-based differences in patients with glioblastoma. Neuro-Oncology Advances 2020; 2(1) doi: 10.1093/noajnl/vdaa039
|
| 14 |
Chang-Yu Chen, Yung-Song Lin, Chi-Long Chen, Pin-Zhir Chao, Jeng-Fong Chiou, Chia-Chun Kuo, Fei-Peng Lee, Yung-Feng Lin, Yu-Hsuan Sung, Yun-Tien Lin, Chang-Fan Li, Yin-Ju Chen, Chien-Ho Chen. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma. Oncotarget 2015; 6(29): 26946 doi: 10.18632/oncotarget.4521
|
| 15 |
Yi Shen, Wei Xiong, Qi Gu, Qin Zhang, Jia Yue, Changsong Liu, Duan Wang. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.654635
|
| 16 |
Yanjie Huang, Mengzhen Jia, Xiaoqing Yang, Hongyan Han, Gailing Hou, Liangliang Bi, Yueli Yang, Ruoqi Zhang, Xueru Zhao, Chaoqun Peng, Xinshou Ouyang. Annexin A2: The diversity of pathological effects in tumorigenesis and immune response. International Journal of Cancer 2022; 151(4): 497 doi: 10.1002/ijc.34048
|
| 17 |
Lei Tang, Jin-Xia Liu, Zi-Juan Zhang, Chen-Zhou Xu, Xue-Ning Zhang, Wei-Rong Huang, Dan-Hua Zhou, Rong-Rong Wang, Xu-Dong Chen, Ming-Bing Xiao, Li-Shuai Qu, Cui-Hua Lu. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis. Pathology - Research and Practice 2019; 215(6): 152386 doi: 10.1016/j.prp.2019.03.015
|
| 18 |
Yingyi Ma, Haiye Wang. Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84675-y
|
| 19 |
Junfeng Chen, Guocheng Wang, Donghai Zhang, Xiaomei Luo, Da Zhang, Yongli Zhang. Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1075431
|
| 20 |
XIAO-HENG XU, WEI PAN, LI-HUA KANG, HUI FENG, YAN-QIU SONG. Association of annexin A2 with cancer development (Review). Oncology Reports 2015; 33(5): 2121 doi: 10.3892/or.2015.3837
|
| 21 |
Aase M. Raddum, Hanne Hollås, Igor A. Shumilin, Petra Henklein, Robert Kretsinger, Torgils Fossen, Anni Vedeler. The native structure of annexin A2 peptides in hydrophilic environment determines their anti-angiogenic effects. Biochemical Pharmacology 2015; 95(1): 1 doi: 10.1016/j.bcp.2015.02.013
|
| 22 |
Sai Ma, Junping Cheng, Haiyan Wang, Ningling Ding, Feng Zhou, Runing Ji, Li Zhu, Chuanwu Zhu, Yunzhi Pan. A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells. Carcinogenesis 2021; 42(1): 93 doi: 10.1093/carcin/bgaa055
|
| 23 |
Raquel Ordoñez, Sara Carbajo‐Pescador, Néstor Prieto‐Dominguez, Andrés García‐Palomo, Javier González‐Gallego, José L. Mauriz. Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. Journal of Pineal Research 2014; 56(1): 20 doi: 10.1111/jpi.12092
|
| 24 |
Ajab Khan, Kuohai Fan, Na Sun, Wei Yin, Yaogui Sun, Panpan Sun, Ali Raza Jahejo, Hongquan Li. Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells in vitro. International Journal of Biological Macromolecules 2019; 140: 1249 doi: 10.1016/j.ijbiomac.2019.08.212
|
| 25 |
Maria Christensen, Claus H�gdall, Kirsten Jochumsen, Estrid H�gdall. Annexin A2 and cancer: A systematic review. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4197
|
| 26 |
Hanne Hollås, Juan Ramirez, Yves Nominé, Camille Kostmann, Angelo Toto, Stefano Gianni, Gilles Travé, Anni Vedeler. The cooperative folding of annexin A2 relies on a transient nonnative intermediate. Biophysical Journal 2022; 121(23): 4492 doi: 10.1016/j.bpj.2022.10.043
|
| 27 |
Li-Wei Qiu, Yi-Fei Liu, Xiao-Qing Cao, Yan Wang, Xiao-Hong Cui, Xian Ye, Shuo-Wen Huang, Hong-Jun Xie, Hai-Jian Zhang. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis <i>via</i> the immune microenvironment. World Journal of Gastroenterology 2020; 26(18): 2126-2137 doi: 10.3748/wjg.v26.i18.2126
|
| 28 |
Hongyan Li, Yecheng Wang, Yinying Lu, Fei Li. Annexin A2 interacting with ELMO1 regulates HCC chemotaxis and metastasis. Life Sciences 2019; 222: 168 doi: 10.1016/j.lfs.2019.03.003
|
| 29 |
Min Yao, Li Wang, Junling Yang, Xiaodi Yan, Yin Cai, Dengfu Yao. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo. Tumor Biology 2016; 37(11): 14677 doi: 10.1007/s13277-016-5296-3
|
| 30 |
Yong-ying Qin, Su-ning Huang, Gang Chen, Yu-yan Pang, Xiao-jiao Li, Wen-wen Xing, Dan-ming Wei, Yun He, Min-hua Rong, Xiao-zhun Tang. Clinicopathological value and underlying molecular mechanism of annexin A2 in 992 cases of thyroid carcinoma. Computational Biology and Chemistry 2020; 86: 107258 doi: 10.1016/j.compbiolchem.2020.107258
|
| 31 |
Jing Gu, Yinni Ma, Lijia Yang, Feng Wang, Cao Lei, Jianxin Zhai, Rushan Xia. Role of Annexin A2 isoform 2 on the aggregative growth of dermal papillae cells. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180971
|
| 32 |
Haijian Zhang, Min Yao, Wei Wu, Liwei Qiu, Wenli Sai, Junling Yang, Wenjie Zheng, Jianfei Huang, Dengfu Yao. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Tumor Biology 2015; 36(12): 9373 doi: 10.1007/s13277-015-3678-6
|
| 33 |
Sai Ma, Chen-Chen Lu, Li-Yan Yang, Juan-Juan Wang, Bo-Shi Wang, Hong-Qing Cai, Jia-Jie Hao, Xin Xu, Yan Cai, Yu Zhang, Ming-Rong Wang. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0851-y
|
| 34 |
Rui Xie, Jia Liu, Xuefeng Yu, Chunfeng Li, Yufeng Wang, Wei Yang, Jiahe Hu, Ping Liu, Hong Sui, Peiqiang Liang, Xinyan Huang, Lijuan Wang, Yuxian Bai, Yingwei Xue, Jiuxin Zhu, Tianyi Fang. ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4035460
|
| 35 |
Chang-Yu Chen, Yung-Song Lin, Chien-Ho Chen, Yin-Ju Chen. Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0430-8
|
| 36 |
Soumaya Menadi, Burak Kucuk, Ercan Cacan. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Biochemical Genetics 2023; doi: 10.1007/s10528-023-10577-5
|
| 37 |
Xiaoyu Zhou, Wei Wang, Shu Zhang, Xudong Wang, Zhiyuan Tang, Jun Gu, Jun Li, Jianan Huang. CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/6136401
|
| 38 |
Xiang Cao, Zhiyuan Tang, Fang Huang, Qin Jin, Xiaoyu Zhou, Jiahai Shi. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer. Oncotarget 2017; 8(8): 12812 doi: 10.18632/oncotarget.14559
|
| 39 |
Anis Askarizadeh, Amirhossein Sahebkar. Curcumin-Based Nanomedicines as Cancer Therapeutics. 2024; : 257 doi: 10.1016/B978-0-443-15412-6.00015-5
|